Churchill Capital Corp XI (CCXI)vsRange Capital Acquisition Corp. Ordinary Shares (RANG)
CCXI
Churchill Capital Corp XI
$10.42
-0.10%
FINANCIAL SERVICES · Cap: $677.31M
RANG
Range Capital Acquisition Corp. Ordinary Shares
$10.61
+0.19%
FINANCIAL SERVICES · Cap: $170.32M
Smart Verdict
WallStSmart Research — data-driven comparison
RANG leads profitability with a 0.0% profit margin vs 0.0%. RANG earns a higher WallStSmart Score of 37/100 (F).
CCXI
Avoid24
out of 100
Grade: F
RANG
Hold37
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Every $100 of equity generates 76 in profit
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 4.7% — below average capital efficiency
0.0% revenue growth
Smaller company, higher risk/reward
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : CCXI
CCXI has a balanced fundamental profile.
Bull Case : RANG
The strongest argument for RANG centers on Return on Equity.
Bear Case : CCXI
The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.
Bear Case : RANG
The primary concerns for RANG are Revenue Growth, Market Cap, Profit Margin. A P/E of 44.3x leaves little room for execution misses.
Key Dynamics to Monitor
RANG is growing revenue faster at 0.0% — sustainability is the question.
RANG generates stronger free cash flow (-233,930), providing more financial flexibility.
Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RANG scores higher overall (37/100 vs 24/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Churchill Capital Corp XI
FINANCIAL SERVICES · SHELL COMPANIES · USA
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.
Range Capital Acquisition Corp. Ordinary Shares
FINANCIAL SERVICES · SHELL COMPANIES · USA
Range Capital Acquisition Corp. (RANG) is a specialized special purpose acquisition company (SPAC) dedicated to merging with high-growth technology firms that demonstrate significant potential for market disruption. Leveraging a seasoned management team with deep industry networks, RANG aims to enhance value creation by identifying innovative businesses at the forefront of technological advancements. The company prioritizes disciplined capital allocation and operational excellence to maximize shareholder returns while offering investors strategic access to the rapidly evolving tech sector.
Compare with Other SHELL COMPANIES Stocks
Want to dig deeper into these stocks?